Dose rationalisation of pembrolizumab and nivolumab using pharmacokinetic modelling and simulation and cost analysis

Kayode Ogungbenro, Alkesh Patel, Robert Duncombe, Richard Nuttall, James Clark, Paul Lorigan

Research output: Contribution to journalArticlepeer-review

785 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Dose rationalisation of pembrolizumab and nivolumab using pharmacokinetic modelling and simulation and cost analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science